tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
3.630USD
+0.050+1.40%
收盤 12/24, 13:00美東報價延遲15分鐘
5.99M總市值
虧損本益比TTM

Sonoma Pharmaceuticals Inc

3.630
+0.050+1.40%

關於 Sonoma Pharmaceuticals Inc 公司

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc簡介

公司代碼SNOA
公司名稱Sonoma Pharmaceuticals Inc
上市日期Jan 26, 2007
CEOTrombly (Amy)
員工數量168
證券類型Ordinary Share
年結日Jan 26
公司地址5445 Conestoga Court, Suite 150
城市BOULDER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編80301
電話18007599305
網址https://sonomapharma.com/
公司代碼SNOA
上市日期Jan 26, 2007
CEOTrombly (Amy)

Sonoma Pharmaceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%
地區USD
名稱
營收
佔比
Europe
1.47M
36.56%
United States
1.00M
25.03%
Asia
662.00K
16.49%
Latin America
564.00K
14.05%
Rest of the world
316.00K
7.87%
業務
地區
業務USD
名稱
營收
佔比
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
其他
95.83%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
其他
95.83%
股東類型
持股股東
佔比
Investment Advisor
2.31%
Individual Investor
1.24%
Investment Advisor/Hedge Fund
1.04%
Hedge Fund
0.09%
Research Firm
0.05%
其他
95.27%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
34
106.22K
6.24%
+25.12K
2025Q2
39
61.63K
4.65%
-24.83K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
2023Q2
37
18.70K
7.42%
+4.13K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
18.79K
1.14%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
17.62K
1.07%
+812.00
+4.83%
Jun 30, 2025
Thornton (Bruce)
7.72K
0.47%
-1.00
-0.01%
Jul 08, 2025
Trombly (Amy Moss)
7.68K
0.47%
--
--
Jul 08, 2025
Dvonch (Jerome J)
4.23K
0.26%
-1.00
-0.02%
Jul 08, 2025
Tower Research Capital LLC
1.00K
0.06%
-447.00
-30.89%
Jun 30, 2025
Dal (Poggetto John)
910.00
0.06%
+910.00
--
Jun 20, 2024
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
公告日期
類型
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1

常見問題

Sonoma Pharmaceuticals Inc的前五大股東是誰?

Sonoma Pharmaceuticals Inc的前五大股東如下:
The Vanguard Group, Inc.
持有股份:18.79K
佔總股份比例:1.14%。
Geode Capital Management, L.L.C.
持有股份:17.62K
佔總股份比例:1.07%。
Thornton (Bruce)
持有股份:7.72K
佔總股份比例:0.47%。
Trombly (Amy Moss)
持有股份:7.68K
佔總股份比例:0.47%。
Dvonch (Jerome J)
持有股份:4.23K
佔總股份比例:0.26%。

Sonoma Pharmaceuticals Inc的前三大股東類型是什麼?

Sonoma Pharmaceuticals Inc 的前三大股東類型分別是:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
DRW Securities, LLC

有多少機構持有Sonoma Pharmaceuticals Inc(SNOA)的股份?

截至2025Q3,共有34家機構持有Sonoma Pharmaceuticals Inc的股份,合計持有的股份價值約為106.22K,占公司總股份的6.24% 。與2025Q2相比,機構持股有所增加,增幅為1.60%。

哪個業務部門對Sonoma Pharmaceuticals Inc的收入貢獻最大?

在FY2026Q1,Human Care業務部門對Sonoma Pharmaceuticals Inc的收入貢獻最大,創收3.56M,占總收入的88.54% 。
KeyAI